Olanzapine-induced neuroleptic malignant syndrome in a patient with bipolar affective disorder: Does quetiapine holds the solution?
Neuroleptic Malignant Syndrome (NMS) is a rare, severe and life threatening condition induced by antipsychotic medications. It is commonly encountered with the use of first generation antipsychotics, however cases of NMS have been reported with the use of second generation antipsychotics like Olanza...
Main Authors: | Praveen Tripathi, Hemika Agrawal, Priyanka Goyal, Sujita Kumar Kar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2013-01-01
|
Series: | Industrial Psychiatry Journal |
Subjects: | |
Online Access: | http://www.industrialpsychiatry.org/article.asp?issn=0972-6748;year=2013;volume=22;issue=2;spage=159;epage=160;aulast=Tripathi |
Similar Items
-
Neuroleptic malignant syndrome in a patient with stable dose of olanzapine
by: Manoj Kumar Sahoo, et al.
Published: (2017-01-01) -
Neuroleptic malignant syndrome in a patient with moderate intellectual disability treated with olanzapine: A case report
by: Francesco Piacenza, et al.
Published: (2021-04-01) -
Olanzapine-induced neuroleptic malignant syndrome
by: Pradeep Kumar Saha, et al.
Published: (2017-01-01) -
Olanzapine-Induced Neuroleptic Malignant Syndrome
by: Seyedhamze Hosseini, et al.
Published: (2017-05-01) -
Olanzapine-Induced Diabetic Ketoacidosis and Neuroleptic Malignant Syndrome with Rhabdomyolysis: A Case Report
by: Young Kyoung Sa, et al.
Published: (2013-03-01)